Singular Genomics Systems Q2 2024 Earnings Report $19.60 +0.17 (+0.87%) (As of 05:21 PM ET) Earnings HistoryForecast Singular Genomics Systems EPS ResultsActual EPS-$8.57Consensus EPS -$8.86Beat/MissBeat by +$0.29One Year Ago EPSN/ASingular Genomics Systems Revenue ResultsActual Revenue$0.74 millionExpected Revenue$0.40 millionBeat/MissBeat by +$340.00 thousandYoY Revenue GrowthN/ASingular Genomics Systems Announcement DetailsQuarterQ2 2024Date8/13/2024TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptOMIC Earnings History Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Singular Genomics Systems Earnings HeadlinesSingular Genomics Systems Enters Acquisition Agreement with DeerfieldSan Diego, CA - December 23, 2024 - The biotechnology company Singular Genomics Systems, Inc. (NASDAQ: OMIC) announced on December 22, 2024, that it has entered into a definitive agDecember 25, 2024 | americanbankingnews.comSingular Genomics to be acquired by Deerfield for $20.00 per share in caseDecember 24, 2024 | markets.businessinsider.com3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…January 2, 2025 | True Market Insiders (Ad)SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Singular Genomics Systems, Inc. BuyoutDecember 23, 2024 | markets.businessinsider.comShareholder Alert: Ademi LLP Investigates Whether Singular Genomics Systems, Inc. is Obtaining a Fair Price for Its Public ShareholdersDecember 23, 2024 | tmcnet.comDeerfield to Take Singular Genomics Private in $50.2M DealDecember 23, 2024 | marketwatch.comSee More Singular Genomics Systems Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Singular Genomics Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Singular Genomics Systems and other key companies, straight to your email. Email Address About Singular Genomics SystemsSingular Genomics Systems (NASDAQ:OMIC), a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.View Singular Genomics Systems ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles S&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Upcoming Earnings Schlumberger (1/17/2025)Procter & Gamble (1/22/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
